For the first time since a very very long time we

For the first time since a very very long time we have had nothing but very positive news and updates. I have never seen so many positive comments and news updates since I became a shareholder almost 6/7 years ago.
It’s too bad I will never recommend buying any stocks to anyone I care about since the ones I mentioned to buy this one , vowed to chop my head off as soon as they get a chance!
I swear I was so tempted to share this post with them but I’m gonna stay away and keep this all to myself.
Look at where we are now and go back and read the updates just a few months back. I love where we are and despite being in red at this point , I hve accumulated well over 2m shares and happily lowered my average share price from low 4s. (Yikes). If you can’t get excited over these updates then go hang out w Craig and watch a few good Hulk movies.
Enjoy your weekend everyone.

CytoDyn Engages Leading CRO For Phase II Inflammation Trial

CytoDyn Announces Completion of FDA Meeting on Phase II Study of Leronlimab in Patients with Relapsed/Refractory Microsatellite Stable Colorectal Cancer

CytoDyn Announces Settlement with Amarex Clinical Research LLC

CytoDyn Announces Start of Preclinical MASH Study, Results Expected in Fall 2024

CytoDyn Announces FDA Has Lifted Clinical Hold

What else is left ? Oh ya, our share price , we’ll buy more if you can and hope to meet some of you in Vegas.